View in EDS HTML Full Text PDF Full Text

The G protein‐coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.

Saved in:
Bibliographic Details
Title: The G protein‐coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.
Authors: Guler Kara, Hale1,2 (AUTHOR) hale.guler@harran.edu.tr, Dogan, Eda1 (AUTHOR), Bozok, Vildan1 (AUTHOR), Aktan, Cagdas3 (AUTHOR), Cakiroglu, Ece4,5 (AUTHOR), Eroglu, Zuhal1 (AUTHOR), Aygunes Jafari, Duygu1 (AUTHOR), Korkmaz, Kemal Sami6 (AUTHOR), Senturk, Serif4,5 (AUTHOR), Kosova, Buket1 (AUTHOR)
Source: FEBS Journal. Jul2025, Vol. 292 Issue 14, p3755-3770. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 186671717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The G protein‐coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Guler+Kara%2C+Hale%22">Guler Kara, Hale</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> hale.guler@harran.edu.tr</i><br /><searchLink fieldCode="AR" term="%22Dogan%2C+Eda%22">Dogan, Eda</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bozok%2C+Vildan%22">Bozok, Vildan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aktan%2C+Cagdas%22">Aktan, Cagdas</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cakiroglu%2C+Ece%22">Cakiroglu, Ece</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eroglu%2C+Zuhal%22">Eroglu, Zuhal</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aygunes+Jafari%2C+Duygu%22">Aygunes Jafari, Duygu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Korkmaz%2C+Kemal+Sami%22">Korkmaz, Kemal Sami</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Senturk%2C+Serif%22">Senturk, Serif</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kosova%2C+Buket%22">Kosova, Buket</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22FEBS+Journal%22">FEBS Journal</searchLink>. Jul2025, Vol. 292 Issue 14, p3755-3770. 16p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186671717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/febs.70099
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 16
        StartPage: 3755
    Titles:
      – TitleFull: The G protein‐coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guler Kara, Hale
      – PersonEntity:
          Name:
            NameFull: Dogan, Eda
      – PersonEntity:
          Name:
            NameFull: Bozok, Vildan
      – PersonEntity:
          Name:
            NameFull: Aktan, Cagdas
      – PersonEntity:
          Name:
            NameFull: Cakiroglu, Ece
      – PersonEntity:
          Name:
            NameFull: Eroglu, Zuhal
      – PersonEntity:
          Name:
            NameFull: Aygunes Jafari, Duygu
      – PersonEntity:
          Name:
            NameFull: Korkmaz, Kemal Sami
      – PersonEntity:
          Name:
            NameFull: Senturk, Serif
      – PersonEntity:
          Name:
            NameFull: Kosova, Buket
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: Jul2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1742464X
          Numbering:
            – Type: volume
              Value: 292
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: FEBS Journal
              Type: main
ResultId 1